Literature DB >> 4077253

Bradykinin levels in inflammatory exudates.

M Tissot, D Regoli, J P Giroud.   

Abstract

An enzyme immunoassay was used to measure the levels of bradykinin (BK)-like immunoreactivity in inflammatory exudates provoked by calcium pyrophosphate (CaPP) or carrageenin. BK-like immunoreactivity increased from 4 to 18 ng/ml in exudates provoked by CaPP and collected from 30 min to 3 h after induction of pleurisy. BK levels decreased progressively (from 16 to 3 ng/ml) in the samples collected at 4 and 6 h. BK levels did not increase in exudates provoked by carrageenin. Control samples of exudates provoked by CaPP but not treated with peptidase inhibitors [orthophenanthroline (OPH) or a mixture of EDTA-captopril-thioglycolic acid (ECT)] as well as samples containing one or the other peptidase inhibitors dissolved in saline, were also negative. The present results indicate that an increased production of kinins is detectable only in exudates induced by CaPP and not in those provoked by carrageenin. Our data also suggest that the kinins are rapidly metabolized, both in vitro (in the exudate sample) and in vivo (in the rat pleural cavity).

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4077253     DOI: 10.1007/BF00916341

Source DB:  PubMed          Journal:  Inflammation        ISSN: 0360-3997            Impact factor:   4.092


  11 in total

1.  Studies on the mediators of the acute inflammatory response induced in rats in different sites by carrageenan and turpentine.

Authors:  M Di Rosa; J P Giroud; D A Willoughby
Journal:  J Pathol       Date:  1971-05       Impact factor: 7.996

2.  Comparative pharmacological actions of bradykinin and related kinins of larger molecular weights.

Authors:  M L Reis; L Okino; M Rocha e Silva
Journal:  Biochem Pharmacol       Date:  1971-11       Impact factor: 5.858

3.  Plasma bradykininogen levels in adjuvant arthritis and carrageenan inflammation.

Authors:  C G Van Arman; G W Nuss
Journal:  J Pathol       Date:  1969-11       Impact factor: 7.996

Review 4.  Pharmacology of kinins: their relevance to tissue injury and inflammation.

Authors:  F Marceau; A Lussier; D Regoli; J P Giroud
Journal:  Gen Pharmacol       Date:  1983

5.  Inflammation induced by histamine, serotonin, bradykinin and compound 48-80 in the rat: antagonists and mechanisms of action.

Authors:  H M Maling; M E Webster; M A Williams; W Saul; W Anderson
Journal:  J Pharmacol Exp Ther       Date:  1974-11       Impact factor: 4.030

Review 6.  Kinins in human disease.

Authors:  D L Wilhelm
Journal:  Annu Rev Med       Date:  1971       Impact factor: 13.739

7.  The presence of a kinin in inflammatory synovial effusion from arthritides of varying etiologies.

Authors:  K L Melmon; M E Webster; S E Goldfinger; J E Seegmiller
Journal:  Arthritis Rheum       Date:  1967-02

8.  Some pharmacodynamic properties of carrageenin in the rat.

Authors:  M Di Rosa; L Sorrentino
Journal:  Br J Pharmacol       Date:  1970-01       Impact factor: 8.739

9.  Inflammation in the rat paw due to urate crystals. Involvement of the kinin system.

Authors:  J Damas; G Remacle-Volon; A Adam
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1984-01       Impact factor: 3.000

10.  Mediators of the inflammation induced in the rat paw by carrageenin.

Authors:  P Crunkhorn; S C Meacock
Journal:  Br J Pharmacol       Date:  1971-07       Impact factor: 8.739

View more
  3 in total

1.  Kinetic evaluation of nitric oxide production in pleural exudate after induction of two inflammatory reactions in the rat.

Authors:  C Regnault; M Roch-Arveiller; I Florentin; J P Giroud; E Postaire; M Delaforge
Journal:  Inflammation       Date:  1996-12       Impact factor: 4.092

2.  Changes in histamine and prostaglandins in acute inflammatory air pouch in mice.

Authors:  Y M Sin; C H Tan; S F Chan
Journal:  Agents Actions       Date:  1989-08

3.  Substance-P-like levels in inflammatory exudates.

Authors:  M Tissot; P Pradelles; J P Giroud
Journal:  Inflammation       Date:  1988-02       Impact factor: 4.092

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.